Advertisement

Topics

Companies Related to "Genes versus Environment cytoplasmic BAP1 determines toxic response" [Most Relevant Company Matches] [Advanced Search Results] RSS

14:57 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "Genes versus Environment cytoplasmic BAP1 determines toxic response" found in our extensive corporate database of over 50,000 company records.

Showing "Genes versus Environment cytoplasmic BAP1 determines toxic response" Companies 1–25 of 1,800+

Relevant

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...


Dr. Wieland GmbH & Co. KG

This saying determines our -everyday- way of doing trade. The HugoHäffner Group is known for being one of the pioneers regarding the protection of human and environment. Our aim is not only to respect regulations and laws but if possible to exceed their expectations.

GenHunter Corporation

All living organisms have thousands to tens of thousands of unique genes encoded in their genome, of which only a small fraction, perhaps 15%, are expressed in any individual cell. Therefore, it is the temporal and spatial regulation in gene expression that determines life processes. The course of normal cellular development as well as pathological changes that arise in diseases such as cancer are...


Chlorogen

The idea that culminated in the founding of Chlorogen in 2002 began in the mid 1980s. That's when molecular biologist Professor Henry Daniell became interested in the developing field of plant biotechnology. While he recognized the tremendous potential for plants to produce beneficial novel proteins for foods, medicines and industrial uses, he questioned whether there was a risk that foreign genes...

Church & Dwight, Co., Inc.

Church and Dwight, Co., Inc., headquartered in Princeton, NJ, distributes First Response Early Result Pregnancy Test and other First Response products, including First Response Gold Digital, First Response Rapid Result Pregnancy Test, First Response Easy Read Ovulation Test, First Response Daily Ovulation Test, First Response Fertility Test for Women, and Answer Pregnancy and Ovulation Tests.

Response Genetics Inc.

Response Genetics Inc. has developed PCR-based genetic tests – ResponseDX™ tests – to help physicians make more informed therapeutic treatment decisions for patients with non-small cell lung cancer (NSCLC), gastric cancer and colorectal cancer. The proprietary ResponseDX™ panels include four key genes: excision repair cross-complementin...

TGO (Toxic Gas Ordinance) Technologies Inc.

TGO (Toxic Gas Ordinance) Technologies got its start when as a packager of chlorine it was required to upgrade the safety of its facility in San Jose, CA to comply with the toxic gas model ordinance adopted in Santa Clara County. Drawing upon more than 25 years of experience repacking chlorine gas the founders found it necessary to create new technology that produced a safe and cost-effective syst...

Cognition Therapeutics Inc.

Cognition Therapeutics, Inc. is a leader in the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of diseases, and there are currently no therapeutics available to prevent or block the destru...

Response Genetics, Inc.

Response Genetics Inc. (“RGI”) is focused on the development and sale of molecular diagnostic tests for cancer. RGI’s technologies enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin-embedded specimens. In addition to diagnostic testing services, the Company generates ...

NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fl...

AltheaDx, Inc.

AltheaDx is a commercial stage molecular diagnostics company which focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. AltheaDx’s Research Services’ NGS portfolio includes pre-qualified panels such as AOP™150, Cancer Hotspo...

Ariad Pharmaceuticals Incorporated

ARIAD Pharmaceuticals, Inc. is focused on the discovery and development of novel and proprietary drugs based on its understanding of the inner-workings of cells and the genes involved in disease. The Company has developed a product based on its gene regulation technology to treat graft-versus-host disease, a complication of bone marrow transplantation involving an attack by a patient's immune syst...

Bussolati marketing design

Message determines medium; we can help you identify and execute both. If you need a new website or your current one needs a facelift, you are in good hands with us.

Global Genes

Global Genes is a non-profit organization that operates as one of the leading rare disease patient advocacy groups in the world. Global Genes promotes the needs of the Rare Disease Community under a unifying symbol of hope—the Blue Denim Genes Ribbon™. The organization was born out of humble beginnings, emerging as a grassroots movement in 2009 comprise...

RepairGenes

The aim of the repairGenes site is to be a source of information about DNA repair genes and a useful resource for research on DNA repair.At the moment, the site contains information about a number of DNA repair genes from a set of selected species. The information is organised by organism and by biological process term as defined by the Gene Ontology (GO) project. The coverage of DNA repair genes ...

Arctic Ease

Dedicated to enhancing the treatment of soft tissue injuries, burns and edema through the development and manufacturing of Cryotherapy (cold therapy) products, Arctic Ease employs over 20 and is proud of its Made in the USA status. Based in Phoenixville, PA, the company offers products that are non-toxic, latex-free, biodegradable and safe for the environm...

Emergency Preparedness Systems, LLC

EPS serves the needs of emergency response organizations by helping them prepare for, respond to, and recover from emergencies.We do this through a unique program of thought provoking action based training events, simulations, and rapid e-learning programs. Our disaster response training sessions are informative, interactive, and directly applicable to your environment. Our Code 3 E-Learning Progr...

Response Mine Health

Response Mine Health is a premier, fully HIPAA compliant digital agency that helps health and wellness clients acquire more customers and patients using direct response digital marketing. For the past 15 years, Response Mine Health has generated millions of dollars in new revenue across healthcare companies including Liberty Medical, Hoveround, North Ameri...

Moss Incorporated

For almost a decade, Moss, Inc. has been exclusively dedicated to supplying Stable Liquid Substrates to the marketplace. Headquartered in Maryland with regional offices in California. Moss focuses strictly on "next generation" substrates which are liquid, stable, and non-toxic. Marketing is on a global basis for human and veterinary diagnostics and research. Applications include food, environment,...

Neuropore Therapies Inc.

Neuropore Therapies is developing novel small molecule therapeutics to treat and slow the progression of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. The approach being taken by Neuropore is to target an underlying pathological process common to these disorders – the accumulation of toxic oligomeric aggregates of ...

Neuropore Therapies, Inc.

Neuropore Therapies is developing novel small molecule therapeutics to treat and slow the progression of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. The approach being taken by Neuropore is to target an underlying pathological process common to these disorders – the accumulation of toxic oligomeric aggregates of ...

Gene Network Sciences, Inc.

Gene Network Sciences (http://www.gnsbiotech.com/) is a leader in biosimulation with its ability to derive molecular mechanisms of drugs and diseases directly from molecular profiling and clinical data. Based in Cambridge, Massachusetts, and Ithaca, New York, GNS uses its REFS(TM) technology in pharmaceutical and clinical settings to rapidly turn combinations of genetic, genomic, and clinical meas...

Human Genome Sciences Incorporated

Human Genome Sciences, Inc. is engaged in the research and development of novel, proprietary pharmaceutical and diagnostic products based on the discovery and understanding of the medical utility of genes. Using automated, high-throughput gene sequencing technology, the Company has generated a very large collection of partial human gene sequences, which the Company believes correspond to most of t...

Church and Dwight, Co., Inc.

Church & Dwight, Co., Inc., headquartered in Princeton, NJ, distributes First Response(R) Early Result Pregnancy Test and other First Response(R) products, including First Response(R) Rapid Result Pregnancy Test, First Response(R) Easy Read Ovulation Test, and Answer Pregnancy and Ovulation Tests.

Hyseq Incorporated

Hyseq, Inc. is a biopharmaceutical company with a growing pipeline of product candidates in its genomics-based HyProfileportfolio. The primary product candidates are expressed proteins of novel rare genes discovered through applications of the Company's proprietary HyX platform in conjunction with work performed by its Functional Genomics, Protein Purification and Bioinformatics Groups. The Compan...


More From BioPortfolio on "Genes versus Environment cytoplasmic BAP1 determines toxic response"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks